表紙:バイオシミラーインターロイキンの世界市場(2022年)
市場調査レポート
商品コード
1062943

バイオシミラーインターロイキンの世界市場(2022年)

Biosimilar Interleukins Global Market Report 2022

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 400 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.31円
バイオシミラーインターロイキンの世界市場(2022年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 400 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のバイオシミラーインターロイキン市場について調査し、市場規模や予測、市場力学、セグメント・地域別の市場分析、競合情勢、戦略、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 バイオシミラーインターロイキン市場の特徴

第3章 バイオシミラーインターロイキン市場の動向と戦略

第4章 バイオシミラーインターロイキンに対するCOVID-19の影響

第5章 バイオシミラーインターロイキンの市場規模と成長

  • 市場実績(金額)
    • 市場促進要因
    • 市場抑制要因
  • 市場予測(金額)
    • 市場促進要因
    • 市場抑制要因

第6章 バイオシミラーインターロイキン市場のセグメンテーション

  • 市場実績と予測(金額):タイプ別
  • IL-17
  • IL-23
  • IL-1
  • IL-5
  • IL-6
  • その他
  • 市場実績と予測(金額):アプリケーション別
  • 乾癬
  • 乾癬性関節炎
  • 関節リウマチ
  • 喘息
  • 炎症性腸疾患(IBD)
  • その他
  • 市場実績と予測(金額):流通チャネル別
  • 病院薬局
  • オンライン薬局
  • 小売薬局
  • クリニック
  • 研究

第7章 バイオシミラーインターロイキン市場の地域・国分析

  • 市場実績と予測(金額):地域別
  • 市場実績と予測(金額):国別

第8章 アジア太平洋のバイオシミラーインターロイキン市場

  • 市場概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府のイニシアチブ、規制、規制機関、主要な協会、徴収される税金、法人税の構造、投資、主要企業
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第9章 中国のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第10章 インドのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第11章 日本のバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第12章 オーストラリアのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第13章 インドネシアのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第14章 韓国のバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第15章 西欧のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第16章 英国のバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第17章 ドイツのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第18章 フランスのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第19章 東欧のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第20章 ロシアのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第21章 北米のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第22章 米国のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第23章 南米のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第24章 ブラジルのバイオシミラーインターロイキン市場

  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第25章 中東のバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第26章 アフリカのバイオシミラーインターロイキン市場

  • 市場概要
  • 市場実績と予測(金額):タイプ別
  • 市場実績と予測(金額):アプリケーション別

第27章 バイオシミラーインターロイキン市場の競合情勢と企業プロファイル

  • バイオシミラーインターロイキン市場の競合情勢
  • バイオシミラーインターロイキン市場の企業プロファイル
    • Novartis AG
    • AbbVie Inc.
    • Eli Lilly and Company
    • Regeneron Pharmaceuticals, Inc
    • AstraZeneca

第28章 バイオシミラーインターロイキンのパイプライン分析

第29章 バイオシミラーインターロイキン市場における主な合併と買収

第30章 バイオシミラーインターロイキン市場の将来展望と潜在的分析

第31章 付録

目次
Product Code: h1165

“Biosimilar Interleukins Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar interleukins market.

This report focuses on biosimilar interleukins market which is experiencing strong growth. The report gives a guide to the biosimilar interleukins market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar interleukins? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Biosimilar Interleukins market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar interleukins market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar interleukins market section of the report gives context. It compares the biosimilar interleukins market with other segments of the biosimilar interleukins market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar interleukins indicators comparison.

Scope

Markets Covered:

1) By Type: IL-17; IL-23; IL-1; IL-5; IL-6

2) By Application: Psoriasis; Psoriatic Arthritis; Rheumatoid Arthritis; Asthma; Inflammatory Bowel Disease (IBD); Others

3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies; Clinics; Research Institutes

Companies Mentioned: MabPharm; Gedeon Richter; Bio-Thera Solutions; Sorrento Therapeutics/MabTech; Sunshine Guojian Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Interleukins Market Characteristics

3. Biosimilar Interleukins Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilar Interleukins

5. Biosimilar Interleukins Market Size And Growth

  • 5.1. Global Biosimilar Interleukins Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Biosimilar Interleukins Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Biosimilar Interleukins Market Segmentation

  • 6.1. Global Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • IL-17
  • IL-23
  • IL-1
  • IL-5
  • IL-6
  • Others
  • 6.2. Global Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Asthma
  • Inflammatory Bowel Disease (IBD)
  • Others
  • 6.3. Global Biosimilar Interleukins Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Clinics
  • Research Institutes

7. Biosimilar Interleukins Market Regional And Country Analysis

  • 7.1. Global Biosimilar Interleukins Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Biosimilar Interleukins Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Biosimilar Interleukins Market

  • 8.1. Asia-Pacific Biosimilar Interleukins Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Biosimilar Interleukins Market

  • 9.1. China Biosimilar Interleukins Market Overview
  • 9.2. China Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Biosimilar Interleukins Market

  • 10.1. India Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Biosimilar Interleukins Market

  • 11.1. Japan Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Biosimilar Interleukins Market

  • 12.1. Australia Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Biosimilar Interleukins Market

  • 13.1. Indonesia Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Biosimilar Interleukins Market

  • 14.1. South Korea Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Biosimilar Interleukins Market

  • 15.1. Western Europe Biosimilar Interleukins Market Overview
  • 15.2. Western Europe Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Biosimilar Interleukins Market

  • 16.1. UK Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Biosimilar Interleukins Market

  • 17.1. Germany Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Biosimilar Interleukins Market

  • 18.4. France Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.5. France Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Biosimilar Interleukins Market

  • 19.1. Eastern Europe Biosimilar Interleukins Market Overview
  • 19.2. Eastern Europe Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Biosimilar Interleukins Market

  • 20.1. Russia Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Biosimilar Interleukins Market

  • 21.1. North America Biosimilar Interleukins Market Overview
  • 21.2. North America Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Biosimilar Interleukins Market

  • 22.1. USA Biosimilar Interleukins Market Overview
  • 22.2. USA Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Biosimilar Interleukins Market

  • 23.1. South America Biosimilar Interleukins Market Overview
  • 23.2. South America Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Biosimilar Interleukins Market

  • 24.1. Brazil Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Biosimilar Interleukins Market

  • 25.1. Middle East Biosimilar Interleukins Market Overview
  • 25.2. Middle East Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Biosimilar Interleukins Market

  • 26.1. Africa Biosimilar Interleukins Market Overview
  • 26.2. Africa Biosimilar Interleukins Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Biosimilar Interleukins Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Biosimilar Interleukins Market Competitive Landscape And Company Profiles

  • 27.1. Biosimilar Interleukins Market Competitive Landscape
  • 27.2. Biosimilar Interleukins Market Company Profiles
    • 27.2.1. Novartis AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. AbbVie Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Eli Lilly and Company
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Regeneron Pharmaceuticals, Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. AstraZeneca
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Biosimilar Interleukins Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilar Interleukins Market

30. Biosimilar Interleukins Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer